MedPath

The single-armed confirmatory trial for immediate effectivity and safety of palliative arterial embolization for painful bone metastases. (JIVROSG/J-SUPPORT 1903)

Not Applicable
Recruiting
Conditions
bone metastases
Registration Number
JPRN-UMIN000040794
Lead Sponsor
Japan Interventional Radiology in Oncology Study Group (JIVROSG)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

1)Difficult to hold rest position 2)The patient could not describe pain by Numeric Rating Scale. 3)Preexisting disorders of being allergic to iodinated contrast material 4)Cannot stop anticoagulants and antithrombotic drugs. 5)Qualified ineligible patients being this clinical trial by responsible doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) pain relief at 72 hours after arterial embolization(TAE) 2) adverse events related to TAE 2 weeks after TAE
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath